Avanos Medical Inc
NYSE:AVNS

Watchlist Manager
Avanos Medical Inc Logo
Avanos Medical Inc
NYSE:AVNS
Watchlist
Price: 12.93 USD -1.67%
Market Cap: $600.2m

Wall Street
Price Targets

AVNS Price Targets Summary
Avanos Medical Inc

There are no price targets for AVNS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Avanos Medical Inc Competitors:
Price Targets
WIPRO
Wipro Ltd
12% Upside

Revenue
Forecast

-7% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
-7% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 12 years the compound annual growth rate for Avanos Medical Inc's revenue is -7%. The projected CAGR for the next 3 years is 2%.

Operating Income
Forecast

-13% / Year
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
-59%
Average Miss
-13% / Year
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
-59%
Average Miss

For the last 12 years the compound annual growth rate for Avanos Medical Inc's operating income is -13%. The projected CAGR for the next 3 years is 51%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AVNS's stock price target?
Not Available

AVNS doesn't have any price targets made by Wall Street professionals.

What is Avanos Medical Inc's Revenue forecast?
Projected CAGR
2%

For the last 12 years the compound annual growth rate for Avanos Medical Inc's revenue is -7%. The projected CAGR for the next 3 years is 2%.

What is Avanos Medical Inc's Operating Income forecast?
Projected CAGR
51%

For the last 12 years the compound annual growth rate for Avanos Medical Inc's operating income is -13%. The projected CAGR for the next 3 years is 51%.

Back to Top